Cargando...
Required concentration index quantifies effective drug combinations against hepatitis C virus infection
Successful clinical drug development requires rational design of combination treatments based on preclinical data. Anti-hepatitis C virus (HCV) drugs exhibit significant diversity in antiviral effect. Dose-response assessments can be used to determine parameters profiling the diverse antiviral effec...
Gardado en:
| Publicado en: | Theor Biol Med Model |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7796629/ https://ncbi.nlm.nih.gov/pubmed/33422060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12976-020-00135-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|